EGFR and cancer: To explore the inhibition of EGFR signaling in CRPC, we initially added gefitinib, an EGFR inhibitor used for the treatment of other EGFR-dependent cancers including non-small cell lung cancer, to the C4-2 cell culture medium34,35.